Perspectives from the Healthcare Economist

The Eu Pharmaceutical Package and Most-Favored Nation Pricing – a Paradox in European Policy Design

This is an extract from BecarisPublishing, first published on December 17, 2025. The entire publication can be read here: https://becarispublishing.com/digital-content/blog-post/perspectives-healthcare-economist-eu-pharmaceutical-package-and-most-favored-nation

In the latest Perspectives from the Healthcare Economist guest column, Jason Shafrin and Tiago Beck of FTI Consulting take a close look at how worldwide pricing reforms are influencing pharmaceutical markets across Europe. Expanding on themes from their Fast Facts session at ISPOR Europe 2025, the column highlights the increasing friction between Europe’s access goals and the external policy forces shaping pricing and market dynamics.

Published

January 16, 2026

temp Key Contacts

Jason Shafrin, Ph.D.

Senior Managing Director

Tiago Beck

Senior Consultant

Most Popular Insights

  1. Navigating Tariffs: 10 Strategies to Protect the Bottom Line
  2. The Hidden Risk for Data Centers That No One is Talking About
  3. It’s La La Land Again in Financial Markets
  4. Geopolitical Risk Management: No Longer Just a “Nice to Have”, But a Corporate Imperative
  5. Corporate Sustainability Report

Sign up to get access to FTI Consulting Insights

Subscribe